RTI Surgical Inc. (NASDAQ:RTIX)’s share price fell 2.4% on Tuesday . The stock traded as low as $3.24 and last traded at $3.24, with a volume of 69,589 shares changing hands. The stock had previously closed at $3.32.

Several brokerages have weighed in on RTIX. Zacks Investment Research cut RTI Surgical from a “hold” rating to a “sell” rating in a report on Friday, July 29th. Craig Hallum cut RTI Surgical from a “buy” rating to a “hold” rating and dropped their price objective for the company from $6.00 to $4.00 in a report on Thursday, July 28th.

The company has a market capitalization of $187.18 million and a PE ratio of 45.63. The firm’s 50-day moving average is $3.40 and its 200 day moving average is $3.71.

RTI Surgical (NASDAQ:RTIX) last issued its quarterly earnings data on Wednesday, July 27th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of $0.03 by $0.08. The firm earned $67.60 million during the quarter, compared to analysts’ expectations of $66.52 million. The firm’s revenue was down 5.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.04 earnings per share. Equities analysts anticipate that RTI Surgical Inc. will post $0.10 earnings per share for the current fiscal year.

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.